S. 4318In committeeGovernment & democracy
Senate bill extends breast cancer stamp sales to 2037
Data as of July 11, 2026
This bill extends the breast cancer research postage stamp program from 2027 to 2037, keeping it available for ten more years.45-second read · 5 questions answered below
Decoded
What does this do?
This bill extends the expiration date for a special postage stamp that raises money for breast cancer research. The stamp costs slightly more than a regular stamp, and that extra amount goes to breast cancer research. Without this bill, the Postal Service's authority to sell the stamp would end in 2027; this bill moves that deadline to 2037.
Who does it affect?
Anyone who buys postage stamps could be affected, since they would continue to have the option to buy this stamp.
Why does it matter?
If the bill passes, the stamp remains available for purchase for an additional ten years. If it does not pass, the Postal Service loses the authority to sell the stamp after 2027.
What does it cost, and who pays?
- Costs slightly above standard postage
- Extra funds breast cancer research
Where does it stand?
- Introduced
- Senate committee — You are here
- Senate vote
- House
- President's desk
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
AI-drafted summary. Verify it against the official text before you act on it.
Three steps: where you stand, your script, the call.
Make the callSee how a call works
Official title
Breast Cancer Stamp Reauthorization Act
- Introduced:
- April 16, 2026
- Latest action:
- April 16, 2026
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Read the official bill on Congress.govMake the call
Three steps: where you stand, your script, the call.